Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807891) titled 'Safety and Tolerability of an Ultra Absorbency Menstrual Tampon Compared to a Commercially Marketed Tampon' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Other. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Lyv Life Inc. (dba: Cora)
Condition:
Safety and Tolerability in Healthy Volunteers
Intervention:
Device: Tampon
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: September 10, 2026
Target Sample Size: 120
Countries of Recruitment:
United St...